SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Pastimes : Can the average (?) moron beat the averages? -- Ignore unavailable to you. Want to Upgrade?


To: Steve Felix who wrote (1240)7/29/2003 1:26:04 AM
From: quasi-geezer  Read Replies (1) | Respond to of 1660
 
news.tradingcharts.com

they have a target for this CSCA at 24 cents

siliconinvestor.com
currently trading at a nickel ...



To: Steve Felix who wrote (1240)7/30/2003 1:12:25 PM
From: quasi-geezer  Respond to of 1660
 
biz.yahoo.com

Its core focus is on commercialization of the TAP technology, a cancer immuno-therapy based on restoration of antigen presentation through transporters associated with antigen-processing technologies (for which the Company owns the license), as the basis for cancer vaccines.

what the fark is that ???

dude, I am doing some research into companies that deals with cancer, how about BOCX and GMXX ...